Mind Games: The Future of an Alzheimer’s Treatment and Why It’s So Controversial

FDA Adviser Dr. Caleb Alexander of John’s Hopkins talks about Aducanumab/Aduhelm: a groundbreaking Alzheimer’s treatment sent to market in one of the most controversial FDA approvals ever.

Subscribe to my two podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Hours.” Leave a review, subscribe and share with your friends! Support independent journalism by visiting the new Sharyl Attkisson store.

Order “Slanted: How the News Media Taught Us to Love Censorship and Hate Journalism” by Sharyl Attkisson at Harper Collins, Amazon, Barnes & Noble, Books a Million, IndieBound, Bookshop!

Visit JustTheNews.com, SharylAttkisson.com and www.FullMeasure.news for original reporting. 

Do your own research. Make up your own mind. Think for yourself.